Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
16,459
+1,082
+7% +$272K 0.03% 453
2025
Q4
$4.37M Buy
15,377
+657
+4% +$205K 0.04% 389
2025
Q3
$4.68M Buy
14,720
+635
+5% +$199K 0.04% 364
2025
Q2
$4.43M Buy
14,085
+1,003
+8% +$289K 0.04% 366
2025
Q1
$3.44M Hold
13,082
0.04% 408
2024
Q4
$3.42M Sell
13,082
-1,098
-8% -$277K 0.03% 419
2024
Q3
$3.3M Sell
14,180
-342
-2% -$70.2K 0.03% 448
2024
Q2
$2.93M Buy
14,522
+88
+0.6% +$15.9K 0.03% 458
2024
Q1
$2.47M Hold
14,434
0.03% 491
2023
Q4
$3.13M Hold
14,434
0.04% 411
2023
Q3
$2.3M Sell
14,434
-43
-0.3% -$9.63K 0.03% 474
2023
Q2
$4.17M Buy
14,477
+1,374
+10% +$417K 0.05% 334
2023
Q1
$4.18M Buy
13,103
+234
+2% +$69.4K 0.06% 314
2022
Q4
$3.79M Buy
12,869
+1,192
+10% +$329K 0.06% 319
2022
Q3
$2.68M Buy
11,677
+456
+4% +$114K 0.05% 369
2022
Q2
$2.45M Buy
11,221
+805
+8% +$183K 0.04% 396
2022
Q1
$2.77M Buy
10,416
+1,817
+21% +$446K 0.04% 398
2021
Q4
$2.29M Sell
8,599
-128
-1% -$37.1K 0.04% 416
2021
Q3
$2.48M Hold
8,727
0.05% 373
2021
Q2
$2.4M Buy
8,727
+2,063
+31% +$561K 0.05% 395
2021
Q1
$1.74M Buy
6,664
+421
+7% +$113K 0.05% 404
2020
Q4
$1.6M Buy
6,243
+874
+16% +$217K 0.05% 358
2020
Q3
$1.27M Buy
5,369
+823
+18% +$173K 0.05% 334
2020
Q2
$883K Sell
4,546
-1,254
-22% -$240K 0.05% 380
2020
Q1
$1.01M Sell
5,800
-35
-0.6% -$6.4K 0.05% 372
2019
Q4
$999K Buy
+5,835
New +$972K 0.04% 475

Other funds holding PODD

IFM Investors's PODD Position: Q1 2026 in Review

IFM Investors increased its Insulet (PODD) stake by 7% in Q1 2026, buying an estimated $272K and bringing the position to 16,459 shares worth $3.45M. The position accounts for 0.03% of the portfolio, ranked #453.

IFM Investors first reported a position in PODD in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.68M in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • IFM Investors held 16,459 shares of Insulet worth $3.45M as of Q1 2026.
  • IFM Investors bought 1,082 Insulet shares in Q1 2026, an estimated $272K.
  • Insulet made up 0.03% of IFM Investors's portfolio in Q1 2026, its #453 holding.
  • IFM Investors first reported a position in Insulet in Q4 2019 and has held it in 26 quarters since.
  • IFM Investors's Insulet position peaked at $4.68M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on IFM Investors's 13F filing for Q1 2026, filed 24 Apr 2026.